Robanul en es it fr

Robanul Brand names, Robanul Analogs

Robanul Brand Names Mixture

  • No information avaliable

Robanul Chemical_Formula


Robanul RX_link

Robanul fda sheet

Robanul FDA

Robanul msds (material safety sheet)

Robanul MSDS

Robanul Synthesis Reference

No information avaliable

Robanul Molecular Weight

318.431 g/mol

Robanul Melting Point

192.5 oC

Robanul H2O Solubility

No information avaliable

Robanul State


Robanul LogP


Robanul Dosage Forms

Liquid; Tablet

Robanul Indication

For use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions, to reduce the volume and free acidity of gastric secretions and to block cardiac vagal inhibitory reflexes during induction of anesthesia and intubation.

Robanul Pharmacology

Glycopyrrolate decreases acid secretion in the stomach. Hence it can be used for treating ulcers in the stomach and small intestine, in combination with other medications. In anesthesia, glycopyrrolate injection serves as a preoperative antimuscarinic operation that reduces salivary, tracheobronchial, and pharyngeal secretions, as well as decreases the acidity of gastric secretions blocks cardiac vagal inhibitory reflexes during intubation

Robanul Absorption

Rapidly absorbed (1-2 minutes) after intravenous injection

Robanul side effects and Toxicity

Side effects include dry mouth, difficult urinating, heachaches, diarrhea and constipation. The medication also induces drowsiness or blurred vision. LD50=709 mg/kg (rat, oral).

Robanul Patient Information

No information avaliable

Robanul Organisms Affected

Humans and other mammals